ACRV vs AVB · $65.1M cap vs P/E 23, rev $3.04B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus AvalonBay Communities Inc (AVB) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
ACRV currently screens at market cap $65.1M. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Not investment advice. Open the ACRV and AVB stock pages for the full models.
Not investment advice.